Showing results (91-100 of 433) with videos related to

Sort By:
Pageof 44
Digestion|December 17, 2018
Minimally Invasive Function-Preserving Gastrectomy with Sentinel Node Biopsy for Early Gastric CancerYoshishiro Hiramatsu, Hiroya Takeuchi, Osamu Goto, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Gastric Cancer in Asia: Unique Features and ManagementTomoyuki Irino, Hiroya Takeuchi, Masanori Terashima, et al.
World Journal of Gastrointestinal Endoscopy|November 14, 2015
Cutting edge of endoscopic full-thickness resection for gastric tumorTadateru Maehata, Osamu Goto, Hiroya Takeuchi, et al.
Digestion|July 1, 2010
Molecular diagnosis and translymphatic chemotherapy targeting sentinel lymph nodes of patients with early gastrointestinal cancersHiroya Takeuchi, Masakazu Ueda, Takashi Oyama, et al.
Nihon Geka Gakkai Zasshi|March 6, 2013
[Clinical significance of micrometastases in patients with esophageal cancer]Hiroya Takeuchi, Hirofumi Kawakubo, Yoshiro Saikawa, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|March 23, 2023
Oncological and physiological impact of thoracic duct resection in esophageal cancerSatoru Matsuda, Masashi Takeuchi, Hirofumi Kawakubo, et al.
Esophagus : Official Journal of the Japan Esophageal Society|April 7, 2021
Whole exome sequencing and deep sequencing of esophageal squamous cell carcinoma and adenocarcinoma in Japanese patients using the Japanese version of the Genome Atlas, JCGAEisuke Booka, Yasuhiro Tsubosa, Tomoya Yokota, et al.
Annals of Medicine and Surgery (2012)|January 25, 2021
Utility of the evaluation of blood flow of remnant esophagus with indocyanine green in esophagectomy with jejunum reconstruction: Case seriesKenjiro Ishii, Yasuhiro Tsubosa, Junichi Nakao, et al.
International Journal of Cancer|June 30, 2005
Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccineHiroya Takeuchi, Donald L Morton, David Elashoff, et al.
BMC Cancer|April 12, 2025
A phase I/II trial evaluating the safety of increased-dose S- 1 with oxaliplatin and nivolumab in HER2-negative advanced gastric cancerKeisuke Baba, Nobumi Suzuki, Chiyo K Imamura, et al.
Pageof 44